Multiple Myeloma and Cancer News
New Shingles Vaccine Shingrix: What You Need To Know
In October 2017, the FDA approved a new shingles vaccine, called Shingrix. New Shingles Vaccine.docx
Cancer Incidence among Pesticide Applicators Exposed to Permethrin in the Agricultural Health Study
Permethrin is a chemical that makes insect repellant clothing.
"We found no associations between permethrin and all malignant neoplasms combined, or between permethrin and melanoma, non-Hodgkin lymphoma, leukemia, or cancers of the colon, rectum, lung, or prostate. We found elevated and statistically significant risks for multiple myeloma in the highest tertiles of both lifetime exposure-days (RR = 5.72; 95% CI, 2.76–11.87) and intensity-weighted lifetime exposure-days (RR = 5.01; 95% CI, 2.41–10.42), compared with applicators reporting they never used permethrin; these results are based on only 15 exposed cases. These findings were similar across a variety of alternative exposure metrics, exposure categories, and reference groups."
“Managing Peripheral Neuropathy, A Guide For People With Myeloma” from Myeloma Australia.
If you get a chance to read this one, it is worth your time. Very interesting and I learned much more about peripheral neuropathy. It is attached for those folks that have internet capability. Click here to download the PDF file.
New Study to Create and Test Personalized Vaccine Against Multiple Myeloma. Click here to download the Word document.
UW Health surgeon, Dr. Ben Marcus will be participating in “Moving Mountains for Multiple Myeloma” to raise money and awareness. In March of 2018, he will join a team of doctors, nurses, researchers, and patients to climb to the base camp of Mt. Everest. Every dollar raised goes to the Multiple Myeloma Research Foundation's valuable efforts to treat and cure this disease. Ben Marcus was recently diagnosed in December 2016.
Check out Ben's donation page for more information:
The New York Times December 3, 2016
This article is a must read. Immunotherapy drugs are an exciting option for some patients. They are not without sometimes serious and life-threatening side effects. They offer real
promise but real risks. Google the above title and learn about the new immunotherapy drugs.
Click here to read the article
The International Myeloma Foundation just published the new issue of "Myeloma Today," their quarterly news magazine. The link is below for those interested in reading it.
Heggestad Obituary Kay was a member of the Madison Multiple Myeloma
Support Group. Her self-written obituary is making its way around social
media. Her family was interviewed by Madison Channel 3 for the 6 PM and
10 PM news on Monday, January 16, 2017. The video title is:
Woman's self-written obituary goes viral. You may view it here.
You may contribute stories via email at email@example.com
Our group member, Joe Ripp is just finishing up his 3rd musical CD with 14 original songs. He intends to sell the CDs for $11.99 with 100% of any monies over the production cost to go to UWCCC Trillium Fund. He plans to have a sample CD that we can listen to at our next meeting. His goal is to be able to donate at least $8.00 from every CD to UWCCC Trillium Fund. He does not want any income from this endeavor and intends to give a tax write off to anyone purchasing a CD.
Madison Magazine has announced their top doctors for 2016, chosen by their peers. Dr. Callander was named as one of four winners in the Oncology, Hematological category.
Click here to view the results and scroll down to Oncology, Hematological category (categories are listed in alphabetical order).
A Mouse that Roared: Lori Alf's Fight Against Cancer and the Miracle Cure that Saved Her (Cured of an agressive form of Multiple Myeloma by an immunotherapy)
Two new multiple myeloma drugs approved in one week!
FDA Approves Ninlaro for multiple myeloma
Ebling Library at UW has a number of health databases available free to the public. Click for more information.
Blood cancer treatment may age immune cells as much as 30 years. A news article about autologous stem cell transplant effects. -From Matt
I-O Talks: Immuno Oncology in Multiple Myeloma, a video (12:35 minutes long) presenting new research into treatment for multiple myeloma. -From Kay
says a study found its cancer drug more effective than rival drug (from
the Los Angeles Times)
Amgen says Kyprolis doubles progression-free survival vs Velcade (from Reuters)
FDA Approves Ixazomib,
the First Oral Protease Inhibitor to Treat Myeloma. This Is the Second New
Myeloma Drug Approved This Week
Contact Us or Provide Suggestions to send a new suggestion